cabe ...no doubt its been a borken record from management ... lets see how the next few weeks go ... would be very surprised if we dont get some sort of positive news before end of this quarter
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%